Live Breaking News & Updates on Cangzhou Chuangrong

Stay updated with breaking news from Cangzhou chuangrong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chinese biotech firm HighTide Therapeutics slashes Hong Kong IPO size by 80% to US$35.6 million

Shenzhen-based HighTide Therapeutics is aiming to raise HK$278 million (US$35.6 million) from an IPO in Hong Kong, a fraction of the originally planned US$200 million. ....

Hong Kong , China General , Mayer Brown , Jerome Powell , Cangzhou Chuangrong , Alibaba Group Holding , Yuthai Fund , Yuexiu Fund , Huatai International , Federal Reserve , China Development Bank Capital , Healthcare Fund Of Guangdong , Hong Kong Exchanges , Robert Lui , Deloitte China , Chairman Jerome Powell , Hang Seng Index , China Development Bank , Hang Seng ,